Related by context. Frequent words. (Click for all words.) 73 Tolerability 67 Pharmacokinetic 66 efficacy 66 Monotherapy 65 Pharmacokinetics 63 Combination Therapy 62 Clopidogrel 62 Phase III Trial 61 Randomized 59 tolerability 58 ziprasidone 58 Postmenopausal Women 57 Clinical Study 57 placebo controlled 57 Completes Enrollment 57 Gemcitabine 57 tiotropium 56 pharmacodynamic 56 Drug Candidate 56 noninferiority 56 peginterferon alfa 2b 56 adalimumab 56 bosentan 56 non inferiority 56 Relapsed 55 multicenter randomized double 55 Endpoints 55 Prophylaxis 55 dose regimens 55 Adjuvant 55 Cost Effectiveness 55 Rosuvastatin 55 tolerability profile 55 randomized placebo controlled 55 Rivaroxaban 55 mg BID 55 randomized clinical 54 Ribavirin 54 prospective randomized 54 demonstrated statistically significant 54 lacosamide 54 blind randomized placebo 54 Bevacizumab 54 Myocardial Infarction 54 mg dose 54 Nasal Spray 54 tocilizumab 54 randomized 54 FOLFOX 53 double blind placebo 53 Effectiveness 53 Initiates Phase 53 secondary endpoints 53 Lantus R 53 Secondary endpoints 53 immunogenicity 53 randomized double 53 randomized controlled clinical 53 serum phosphorus 53 Non Invasive 53 Clinical Trial 53 pioglitazone 53 placebo controlled trials 53 Prophylactic 53 plus methotrexate 53 FOLFIRI 53 TMC# [001] 53 monotherapy 52 aripiprazole 52 Coronary Stent 52 antiviral activity 52 Olanzapine 52 multicenter 52 tolerated dose MTD 52 mcg kg 52 decitabine 52 Potency 52 etanercept 52 Taxotere R 52 Abstract # 52 certolizumab pegol 52 LIALDA 52 efficacy endpoints 52 plus ribavirin 52 Dexamethasone 52 Ezetimibe 52 Secondary endpoints include 52 Percutaneous 52 randomized trials 52 lopinavir ritonavir 52 SPIRIT III 52 prespecified 52 Phase 1b 52 Phase 1b trial 52 FDA Approves 52 pharmacokinetic 51 azacitidine 51 statistically significant improvement 51 pharmacokinetic profile 51 Methotrexate 51 Pharmacological